| Medicinal Organometallic Chemistry R Alberto, C Biot, A Casini, D Dive, PJ Dyson, S Gibaud, A Habtermariam, ... Topics in Organometallic Chemistry 32, 2010 | 189* | 2010 |
| Microemulsions for oral administration and their therapeutic applications S Gibaud, D Attivi Expert opinion on drug delivery 9 (8), 937-951, 2012 | 125 | 2012 |
| Arsenic-based drugs: from fowler’s solution to modern anticancer chemotherapy S Gibaud, G Jaouen Medicinal organometallic chemistry, 1-20, 2010 | 119 | 2010 |
| Increased bone marrow toxicity of doxorubicin bound to nanoparticles S Gibaud, JP Andreux, C Weingarten, M Renard, P Couvreur European Journal of Cancer 30 (6), 820-826, 1994 | 114 | 1994 |
| Cells involved in the capture of nanoparticles in hematopoietic organs S Gibaud, M Demoy, JP Andreux, C Weingarten, B Gouritin, P Couvreur Journal of pharmaceutical sciences 85 (9), 944-950, 1996 | 93 | 1996 |
| Melarsoprol–cyclodextrins inclusion complexes S Gibaud, SB Zirar, P Mutzenhardt, I Fries, A Astier International journal of pharmaceutics 306 (1-2), 107-121, 2005 | 92 | 2005 |
| Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis J Rodgers, A Jones, S Gibaud, B Bradley, C McCabe, MP Barrett, ... PLoS Neglected Tropical Diseases 5 (9), e1308, 2011 | 82 | 2011 |
| Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF) S Gibaud, C Rousseau, C Weingarten, R Favier, L Douay, JP Andreux, ... Journal of controlled release 52 (1-2), 131-139, 1998 | 80 | 1998 |
| Splenic trapping of nanoparticles: complementary approaches for in situ studies M Demoy, S Gibaud, JP Andreux, C Weingarten, B Gouritin, P Couvreur Pharmaceutical research 14, 463-468, 1997 | 72 | 1997 |
| Comparison of nanosuspensions and hydroxypropyl-β-cyclodextrin complex of melarsoprol: Pharmacokinetics and tissue distribution in mice S Ben Zirar, A Astier, M Muchow, S Gibaud European Journal of Pharmaceutics and Biopharmaceutics 70 (2), 649-656, 2008 | 69 | 2008 |
| Development of microemulsion of mitotane for improvement of oral bioavailability D Attivi, I Ajana, A Astier, B Demoré, S Gibaud Drug development and industrial pharmacy 36 (4), 421-427, 2010 | 52 | 2010 |
| Poly (ε-caprolactone) and Eudragit® microparticles containing fludrocortisone acetate S Gibaud, NJ Al Awwadi, C Ducki, A Astier International journal of pharmaceutics 269 (2), 491-508, 2004 | 46 | 2004 |
| Preparation of 3, 4-diaminopyridine microparticles by solvent-evaporation methods S Gibaud, A Bonneville, A Astier International journal of pharmaceutics 242 (1-2), 197-201, 2002 | 32 | 2002 |
| Acceptability of oral liquid pharmaceutical products in older adults: Palatability and swallowability issues E Belissa, T Vallet, S Laribe-Caget, A Chevallier, FX Chedhomme, ... BMC geriatrics 19, 1-9, 2019 | 31 | 2019 |
| Thiomers and their potential applications in drug delivery KU Shah, SU Shah, N Dilawar, GM Khan, S Gibaud Expert Opinion on Drug Delivery 14 (5), 601-610, 2017 | 27 | 2017 |
| A decision support tool facilitating medicine design for optimal acceptability in the older population T Vallet, E Belissa, S Laribe-Caget, A Chevallier, FX Chedhomme, ... Pharmaceutical research 35, 1-12, 2018 | 26 | 2018 |
| (2-Phenyl-[1, 3, 2] dithiarsolan-4-yl)-methanol derivatives show in vitro antileukemic activity S Gibaud, R Alfonsi, P Mutzenhardt, I Fries, A Astier Journal of organometallic chemistry 691 (5), 1081-1084, 2006 | 23 | 2006 |
| Cyclodextrin inclusion complexes of the central analgesic drug nefopam H Brun, M Paul, N Razzouq, M Binhas, S Gibaud, A Astier Drug development and industrial pharmacy 32 (10), 1123-1134, 2006 | 23 | 2006 |
| Synthesis of S-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines SU Shah, M Socha, I Fries, S Gibaud Drug delivery 23 (8), 2927-2935, 2016 | 20 | 2016 |
| Slow-release melarsoprol microparticles S Gibaud, A Gaia, A Astier International journal of pharmaceutics 243 (1-2), 161-166, 2002 | 19 | 2002 |
Alain ASTIEROncotask and European Society Oncology Pharmacy (ESOP)Bestätigte E-Mail-Adresse bei aphp.fr